Showing posts with label always. Show all posts
Showing posts with label always. Show all posts

Tuesday, 27 August 2013

'You'll always make mistakes ... it's about correcting them'

Jan Filochowski 'There isn't a single measure of failure', says Jan Filochowski, who has 20 years of experience as an NHS chief executive.

For Jan Filochowski, failure is not the end. The chief executive of Great Ormond Street Hospital is trying to change a management culture where it is assumed there can be no return from failure. "I want failure to be a point and success to be a permanent long lasting state", he says. "If you get into that mindset, you approach things differently."

It is this message that permeates his recent book, Too Good to Fail?, and it is one that he wants more people to adopt.

Having managed organisations in all states from failing to world-leading, Filochowski was inspired to write about the patterns he identified which occur when things were going wrong. If left unchecked, his book argues, simple problems can multiply until they result in total failure. Too Good to Fail? covers the full spectrum of failure from minor mistakes to complete systemic collapse.

At a time when the NHS is perceived to be in crisis with negative stories hitting the headlines, Filochowski – who has 20 years' experience as an NHS chief executive and troubleshooter – wants to change the way people think about failing.

"[People ask] what's the perfect hospital? Who's the perfect manager?," he says. "I think that's wrong. One of the words I'm most suspicious of is 'best' or 'perfect' and words I like are better [are] 'good' because I don't think you can ever do anything well enough. And if you do, you've got a problem because things can only get worse.

"I don't think that's setting the bar too low," Filochowski adds. "It's setting the bar high enough so people have a chance at jumping over it. If no-one can, it's not the managers that are no good – it's the system that's misjudged how high it should be set."

But what is failure? According to Filochowski, "there isn't a single measure of failure". The parameters change depending on the views of patients, the government of the day or some intermediary body. But, he argues, there is a clear and predictable pattern to failure.

A clear warning sign is when management is convinced that they are right. Other indications of organisational collapse include misjudgement of the problems faced, a failure to respond to what customers are saying, blindness to the consequences of actions, and a lack of oversight of staff and skills.

Filochowski says that openness and listening are key to avoiding and overcoming failure. "If you know the answer already then you don't need to listen, but people rarely do," he says. "I think it's really important that people are consulted and able to give their view. That doesn't mean to say that people taking those decisions have to give way when someone disagrees with them, because you'd never take a decision."

Meanwhile, Filochowski thinks the culture of branding any problems as 'failure' must change. "I think individual organisations need to be able to own up to difficulties without that being seen as a failure. Owning up to problems is a mark of maturity and a real indicator that you are likely to make the best of things."

He recognises that NHS managers have an enormous task ahead of them. "You'll always make mistakes," he explains. "We're managing something incredibly complex and it's about seeing the mistake and correcting it before it becomes really big. I think a lot of the art of management is making the unpredictable, predictable."

As for the future of the NHS, Filochowski predicts a long and healthy life.

"I think the future holds an NHS that, with blips and ups and downs, will continue to improve. The fact that there are loads of things wrong with it doesn't mean it is in terminal failure. They can and will be put right. It will never be perfect. That's because it's good and it's getting better."

This article is published by Guardian Professional. Join the Healthcare Professionals Network to receive regular emails and exclusive offers.


View the original article here

Thursday, 1 August 2013

Reducing resistance to antibiotics via reduction campaigns not always successful

Main Category: MRSA / Drug Resistance
Also Included In: Public Health
Article Date: 31 Jul 2013 - 0:00 PDT Current ratings for:
Reducing resistance to antibiotics via reduction campaigns not always successful
not yet ratednot yet rated

Antibiotic use - and misuse - is the main driver for selection of antibiotic resistant bacteria. This has led many countries to implement interventions designed to reduce overall antibiotic consumption. Now, using methicillin resistant Staphylococcus aureus (MRSA) as an example, Laura Temime of the Conservatoire National des Arts et Metiers, Paris, and collaborators warn that simply reducing antibiotics consumption does not necessarily reduce resistance. The research is published online ahead of print in Antimicrobial Agents and Chemotherapy.

The success of antibiotic reduction programs depends on which antibiotics are reduced, because some select more strongly for resistance than others. For instance, in the case of S. aureus, reducing use of clindamycin and methicillin lead to decreased resistance, while reducing use of penicillins does not, since most S. aureus, including MRSA, are already resistant to penicillin, explains Temime.

Additionally, efforts to reduce antibiotic use must be coordinated between hospitals and the community, since either can feed resistant bacteria into the other, undermining reduction efforts, says Temime.

In 2002-2003, a national program reduced antibiotic use in France by 10 percent. However, it fell short of the full potential for reducing resistance because it failed to target those antibiotics that generate the most resistance, says Temime. She and her collaborators developed a mathematical model of MRSA circulation, which correctly simulated that reduction, post-facto. They then performed a number of simulations of reductions in antibiotic use, which demonstrated the complexities of reduction efforts.

"We found that the reduction in MRSA hospital rates could have been much larger than it actually was following the 2002 antibiotic reduction campaign," says Temime. "Our results also suggest that changes in the distribution of antibiotics prescribed for non-hospitalized patients actually limited the impact of the antibiotic reduction campaign in French hospitals."

Their research shows that class-specific changes in antibiotic use, rather than overall reductions, need to be considered in order to achieve the greatest benefit from antibiotic reduction campaigns, says Temime. "This underlines the importance of generating surveillance data on both antibiotic class-specific changes in antibiotic use and antibiotic resistance in the years following an antibiotic reduction campaign. We believe that this research may help health policy makers and physicians in the design of more efficient antibiotic reduction campaigns."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our mrsa / drug resistance section for the latest news on this subject.

Lidia Kardas-Sloma, Pierre-Yves Boëlle, Lulla Opatowski, Didier Guillemot and Laura Temime, Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant S. aureus, Antimicrobial Agents and Chemotherapy, Published ahead of print 1 July 2013, doi: 10.1128/AAC.00711-13

American Society for Microbiology

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Society for Microbiology. "Reducing resistance to antibiotics via reduction campaigns not always successful." Medical News Today. MediLexicon, Intl., 31 Jul. 2013. Web.
31 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Reducing resistance to antibiotics via reduction campaigns not always successful'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Reducing resistance to antibiotics via reduction campaigns not always successful

Main Category: MRSA / Drug Resistance
Also Included In: Public Health
Article Date: 31 Jul 2013 - 0:00 PDT Current ratings for:
Reducing resistance to antibiotics via reduction campaigns not always successful
not yet ratednot yet rated

Antibiotic use - and misuse - is the main driver for selection of antibiotic resistant bacteria. This has led many countries to implement interventions designed to reduce overall antibiotic consumption. Now, using methicillin resistant Staphylococcus aureus (MRSA) as an example, Laura Temime of the Conservatoire National des Arts et Metiers, Paris, and collaborators warn that simply reducing antibiotics consumption does not necessarily reduce resistance. The research is published online ahead of print in Antimicrobial Agents and Chemotherapy.

The success of antibiotic reduction programs depends on which antibiotics are reduced, because some select more strongly for resistance than others. For instance, in the case of S. aureus, reducing use of clindamycin and methicillin lead to decreased resistance, while reducing use of penicillins does not, since most S. aureus, including MRSA, are already resistant to penicillin, explains Temime.

Additionally, efforts to reduce antibiotic use must be coordinated between hospitals and the community, since either can feed resistant bacteria into the other, undermining reduction efforts, says Temime.

In 2002-2003, a national program reduced antibiotic use in France by 10 percent. However, it fell short of the full potential for reducing resistance because it failed to target those antibiotics that generate the most resistance, says Temime. She and her collaborators developed a mathematical model of MRSA circulation, which correctly simulated that reduction, post-facto. They then performed a number of simulations of reductions in antibiotic use, which demonstrated the complexities of reduction efforts.

"We found that the reduction in MRSA hospital rates could have been much larger than it actually was following the 2002 antibiotic reduction campaign," says Temime. "Our results also suggest that changes in the distribution of antibiotics prescribed for non-hospitalized patients actually limited the impact of the antibiotic reduction campaign in French hospitals."

Their research shows that class-specific changes in antibiotic use, rather than overall reductions, need to be considered in order to achieve the greatest benefit from antibiotic reduction campaigns, says Temime. "This underlines the importance of generating surveillance data on both antibiotic class-specific changes in antibiotic use and antibiotic resistance in the years following an antibiotic reduction campaign. We believe that this research may help health policy makers and physicians in the design of more efficient antibiotic reduction campaigns."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our mrsa / drug resistance section for the latest news on this subject.

Lidia Kardas-Sloma, Pierre-Yves Boëlle, Lulla Opatowski, Didier Guillemot and Laura Temime, Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant S. aureus, Antimicrobial Agents and Chemotherapy, Published ahead of print 1 July 2013, doi: 10.1128/AAC.00711-13

American Society for Microbiology

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Society for Microbiology. "Reducing resistance to antibiotics via reduction campaigns not always successful." Medical News Today. MediLexicon, Intl., 31 Jul. 2013. Web.
31 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Reducing resistance to antibiotics via reduction campaigns not always successful'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here